Faculty Opinions recommendation of PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling.
2013 ◽
Vol 20
(7)
◽
pp. 912-921
◽
2014 ◽
Vol 20
(8)
◽
pp. 1244-1258
◽
2014 ◽
Vol 50
(3)
◽
pp. 797-810
◽